Plain-English translation of NCT06862180 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 2 research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether Contro Eazy NOW, a meal replacement product, can help improve blood sugar control in people with type 2 diabetes whose condition isn't well managed with oral medications alone. Researchers want to see if using this medication instead of regular meals for 12 weeks can lower HbA1c levels (a measure of long-term blood sugar), help with weight loss, and improve other health markers like cholesterol and blood pressure. The study will compare people using the meal replacement to a group receiving standard dietary advice.
Many people with type 2 diabetes struggle to control their blood sugar levels even while taking oral medications. This trial is exploring whether the meal replacement could offer a simpler, more convenient way to help patients achieve better glucose control and improve related health markers.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to either use the meal replacement shakes or receive dietary counseling from a healthcare provider. The intervention lasts 12 weeks. You'll have blood tests at the start and end to measure your blood sugar control, cholesterol, and other metabolic markers, as well as assessments of your weight, body composition, and quality of life. Throughout the study, you'll need to avoid taking other supplements or weight-loss products.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Malaysia